Semaglutide 2.4 mg produces weight-independent liver benefits among individuals with metabolic dysfunction-associated steatohepatitis.
A quality improvement initiative in a hepatology clinic increased alcohol use disorder pharmacotherapy prescriptions from 10% ...
Mortality associated with chronic liver disease (CLD) and metabolic syndrome (MetS) increased substantially from 1999 to 2023 ...
Patients with lean vs nonlean metabolic dysfunction-associated steatotic liver disease (MASLD) have a significantly increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback